Tokyo Tape
Sign in
← K Pharma

Quarterly report · Q3

4896.TEDINET S100S8JN
Period2023-01-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedNo
Data checks9 of 9 passed
Key figures · 22
MetricValuePeriodScopeSource row
Revenue¥1.0bn2023-01-01 → 2023-09-30StandaloneNet sales
Operating income¥516m2023-01-01 → 2023-09-30StandaloneOperating income
Ordinary income¥509m2023-01-01 → 2023-09-30StandaloneOrdinary income
Ordinary income−¥359m2022-01-01 → 2022-12-31StandaloneOrdinary income loss (5-year summary)
Profit before tax¥472m2023-01-01 → 2023-09-30StandaloneIncome before income taxes
Net income¥398m2023-01-01 → 2023-09-30StandaloneProfit loss
Net income−¥392m2022-01-01 → 2022-12-31StandaloneNet income loss (5-year summary)
Total assets¥2.0bnat 2023-09-30StandaloneAssets
Total assets¥1.4bnat 2022-12-31StandaloneAssets
Total liabilities¥247mat 2023-09-30StandaloneLiabilities
Total liabilities¥38mat 2022-12-31StandaloneLiabilities
Net assets / equity¥1.7bnat 2023-09-30StandaloneNet assets
Net assets / equity¥1.3bnat 2022-12-31StandaloneNet assets
Cash and deposits¥1.9bnat 2023-09-30StandaloneCash and deposits
Cash and deposits¥1.3bnat 2022-12-31StandaloneCash and deposits
EPS (basic)¥40.312023-01-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-11.82023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-42.062022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
Equity ratio87.5%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio97.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued9,879,000at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued5,000at 2022-12-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 207
ItemContextValueUnit
Shareholders equityPrior1YearInstant_NonConsolidatedMember1336263000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember1734476000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1336263000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember1734476000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember1374566000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember1981662000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember1000000000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember90000000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember910000000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember394163000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember515836000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember16000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember16000JPY
Going public expenses noeCurrentYTDDuration_NonConsolidatedMember4000000JPY
Stock issuance cost noeCurrentYTDDuration_NonConsolidatedMember3193000JPY
Other noeCurrentYTDDuration_NonConsolidatedMember90000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember7283000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember508569000JPY
Impairment loss elCurrentYTDDuration_NonConsolidatedMember36497000JPY
Extraordinary lossCurrentYTDDuration_NonConsolidatedMember36497000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember472072000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember73859000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember73859000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember398213000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-11-13
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第７期第３四半期(自　2023年７月１日　至　2023年９月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社ケイファーマ
Company name in english cover pageFilingDateInstantK Pharma,Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　福島　弘明
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都港区六本木七丁目７番７号
Telephone number address of registered headquarter cover pageFilingDateInstant03-6629-3380
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役CFO　松本　真佐人
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都港区六本木七丁目７番７号
Telephone number nearest place of contact cover pageFilingDateInstant03-6629-3380
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役CFO　松本　真佐人
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE38985
Fund codeFilingDateInstant－
Security codeFilingDateInstant48960
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社ケイファーマ
Filer name in englishFilingDateInstantK Pharma, Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 9 of 9 passed
balance sheet identitynon_consolidated 2022-12-31pass rounding
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass